TY - JOUR
T1 - Associations between momentary mental states and concurrent social functioning after remission from first episode psychosis
T2 - A HAMLETT ecological momentary assessment study
AU - Djordjevic, M.
AU - Jongsma, H.E.
AU - Simons, C.J.P.
AU - Oomen, P.P.
AU - de Haan, L.
AU - Boonstra, N.
AU - Kikkert, M.
AU - Koops, S.
AU - Geraerts, C.N.W.
AU - Begemann, M.J.H.
AU - Hamlett - Ophelia Consortium
AU - Marcelis, M.
AU - Veling, W.
N1 - Collaborators of the HAMLETT-OPHELIA Consortium are Prof. Dr. Iris Sommer1, Prof. Dr. Lieuwe de Haan2, Prof. Dr. Wim Veling1, Prof. Dr. Jim van Os3,4,5, Prof. Dr. Filip Smit6,7,8, Dr. Marieke Begemann1, Dr. Sanne Koops1, Prof. Dr. Machteld Marcelis4,9, Dr. Martijn Kikkert10, Prof. Dr. Nico van Beveren11,12,13, Prof. Dr. Nynke Boonstra3,13,14, Bram-Sieben Rosema1, Dr. P. Roberto Bakker1,10, Dr. Sinan Gül¨oksüz4,15, Dr. Joran Lokkerbol8, Dr. Ben Wijnen8, Dr. Bodyl Brand1, Dr. Shiral Gang-adin1,3, Erna van ’t Hag1, Dr. Priscilla Oomen1, Dr. Alban Voppel1,16, Franciska de Beer1, Sterre Kamphuis3,4, Iris Hamers1, Matej Djordjevic1, Toon Scheurink1, Prof. Dr. Therese van Amelsvoort4,17, Dr. Maarten Bak4,17, Dr. Steven Berendsen1,18, Truus van den Brink19, Dr. Gunnar Faber20, Prof. Dr. Koen Grootens21,22, Dr. Henderikus Knegtering1,23, Dr. Jörg Kurkamp24, Prof. Dr. Gerdina Hendrika Maria Pijnenborg25,26, Dr. Anton Staring27, Dr. Natalie Veen28, Dr. Selene Veerman29, Sybren Wiersma30, Albert Batalla3, Ruben Curfs31, Jan-Jaap Hage32, Ellen
Graveland20, Joelle Hoornaar11, Martin de Jonge32 and Inge van der Heijden3,33. 1Department of Psychiatry, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands; 2Department of Early Psychosis, Amsterdam UMC, Academic Medical Center, Amsterdam, The Netherlands; 3Department of Psychiatry, UMC Utrecht Brain Center, University Medical Center Utrecht, Utrecht, The Netherlands; 4Department of Psychiatry and Neuropsychology, School for Mental Health and Neuroscience (MHeNs), Maastricht University Medical Centre, Maastricht, The Netherlands; 5King’s College London, King’s Health Partners Department of Psychosis Studies; Institute of Psychiatry,
Psychology & Neuroscience, London, United Kingdom; 6Department of Epidemiology and Biostatistics, Amsterdam Public Health Research Institute, Amsterdam University Medical Centers, location VUmc, Amsterdam, The Netherlands; 7Department of Clinical, Neuro and Developmental Psychology, Amsterdam Public Health Research Institute, Vrije Universiteit, Amsterdam, The Netherlands; 8Centre of Economic Evaluation & Machine Learning, Trimbos Institute (Netherlands Institute of Mental Health), Utrecht, The Netherlands; 9Institute for Mental Health Care Eindhoven (GGzE), Eindhoven, The Netherlands; 10Department of Research, Arkin Mental Health Care, Amsterdam, The
Netherlands; 11Antes Center for Mental Health Care, Rotterdam, The Netherlands; 12Department of Neuroscience, Erasmus MC, Rotterdam, The Netherlands; 13NHL Stenden, University of Applied Sciences, Leeuwarden, The Netherlands; 14KieN VIP Mental Health Care Services, Leeuwarden, The Netherlands; 15Department of Psychiatry, Yale University School of Medicine, New Haven, Connecticut; 16Douglas Mental Health University Center, McGill University, Montr´eal, Canada; 17Mondriaan Mental Health Care, Heerlen, The Netherlands; 18Dimence Institute for Mental Health, Deventer, Zwolle, The Netherlands; 19Early Intervention Team, GGZ Centraal, Amersfoort, The Netherlands; 20Yulius, Mental Health Institute, Dordrecht, The Netherlands; 21Reinier van Arkel Institute for Mental Health Care, ’s Hertogenbosch, The Netherlands; 22Tranzo, TSB, Tilburg University, Tilburg, The
Netherlands; 23Lentis Research, Lentis Psychiatric Institute, Groningen, The Netherlands; 24Center for Youth with Psychosis, Mediant ABC Twente, Enschede, The Netherlands; 25Department of Psychotic Disorders, GGZ-Drenthe, Assen, The Netherlands; 26Department of clinical and developmental neuropsychology, faculty BSS, University of Groningen, Groningen, The Netherlands; 27Department ABC Early Psychosis, Altrecht Psychiatric Institute, Utrecht, The Netherlands; 28GGZ Delfland, Delfland Institute for Mental Health Care, Delft, The Netherlands; 29Community Mental Health, Mental Health Service Noord-Holland Noord, Alkmaar, The Netherlands; 30Early Intervention Psychosis Team, GGZ inGeest Specialized Mental Health Care, Hoofd- dorp, The Netherlands; 31Parnassia Psychiatric Institute, The Hague, The Netherlands; 32GGZ Breburg, Tilburg, The Netherlands; 32Program for Psychosis & Severe Mental Illness, Pro Persona Mental Health, Wolfheze, The Netherlands; 33Janssen-Cilag B.V., Breda, The Netherlands.
PY - 2025/1
Y1 - 2025/1
N2 - Background: Symptom severity and social functioning are important outcomes after first episode psychosis (FEP), yet current evidence about associations between them is inconsistent and lacks (subclinical) momentary insights. Methods: The current Ecological Momentary Assessment (EMA) study was conducted in 58 people in remission from FEP, as part of the HAMLETT (Handling Antipsychotic Medication: Long-term Evaluation of Targeted Treatment) trial. At baseline, participants were prompted to report momentary mental states and social context 10x/day for eight consecutive days, including psychotic experiences (PEs), motivation/drive and negative affect, that may indicate proxies of (subclinical) psychotic, negative and general affective symptoms, respectively. We employed multilevel mixed-effects regressions to investigate associations between self-reported mental states and concurrent activity or social company and subjective appraisal thereof. We also conducted retrospective clinical assessments of symptoms (PANSS) and social functioning (WHODAS 2.0) and investigated their cross-sectional associations using multivariable linear regression. Results: Analyses of 3101 EMA-questionnaires showed that lower motivation/drive was associated with more passive activity and less company (OR = 0.96 [95%CI: 0.96; 0.97], OR = 0.95 [95%CI: 0.93; 0.96], N.B. ORs per 1-point symptom-score change). PEs and negative affect were associated with more proactive activity (OR = 1.02 [95%CI: 1.00; 1.03], OR = 1.02 [95%CI: 1.01; 1.03]). All three mental state domains were associated with lower activity appraisal overall, though activity-specific associations differed. PEs and negative affect were associated with lower company appraisal (B = -0.25 [95%CI: -0.36; -0.14], B = -0.15 [95%CI: -0.23; -0.06]). When assessed retrospectively, only PANSS general psychopathology was associated with poorer social functioning (B = 2.52 [95%CI: 1.69; 3.34]). Conclusion: Self-reported PEs, momentary motivation/drive and general affective symptoms are associated with daily-life functioning after remission from FEP. Retrospective observer-rated and momentary self-report assessment methods do not measure the same aspects or intensity of psychopathology.
AB - Background: Symptom severity and social functioning are important outcomes after first episode psychosis (FEP), yet current evidence about associations between them is inconsistent and lacks (subclinical) momentary insights. Methods: The current Ecological Momentary Assessment (EMA) study was conducted in 58 people in remission from FEP, as part of the HAMLETT (Handling Antipsychotic Medication: Long-term Evaluation of Targeted Treatment) trial. At baseline, participants were prompted to report momentary mental states and social context 10x/day for eight consecutive days, including psychotic experiences (PEs), motivation/drive and negative affect, that may indicate proxies of (subclinical) psychotic, negative and general affective symptoms, respectively. We employed multilevel mixed-effects regressions to investigate associations between self-reported mental states and concurrent activity or social company and subjective appraisal thereof. We also conducted retrospective clinical assessments of symptoms (PANSS) and social functioning (WHODAS 2.0) and investigated their cross-sectional associations using multivariable linear regression. Results: Analyses of 3101 EMA-questionnaires showed that lower motivation/drive was associated with more passive activity and less company (OR = 0.96 [95%CI: 0.96; 0.97], OR = 0.95 [95%CI: 0.93; 0.96], N.B. ORs per 1-point symptom-score change). PEs and negative affect were associated with more proactive activity (OR = 1.02 [95%CI: 1.00; 1.03], OR = 1.02 [95%CI: 1.01; 1.03]). All three mental state domains were associated with lower activity appraisal overall, though activity-specific associations differed. PEs and negative affect were associated with lower company appraisal (B = -0.25 [95%CI: -0.36; -0.14], B = -0.15 [95%CI: -0.23; -0.06]). When assessed retrospectively, only PANSS general psychopathology was associated with poorer social functioning (B = 2.52 [95%CI: 1.69; 3.34]). Conclusion: Self-reported PEs, momentary motivation/drive and general affective symptoms are associated with daily-life functioning after remission from FEP. Retrospective observer-rated and momentary self-report assessment methods do not measure the same aspects or intensity of psychopathology.
KW - Early psychosis
KW - Ecological momentary assessment
KW - Experience sampling method
KW - First episode psychosis
KW - Schizophrenia spectrum disorders
KW - Social functioning
U2 - 10.1016/j.jpsychires.2024.12.002
DO - 10.1016/j.jpsychires.2024.12.002
M3 - Article
C2 - 39708772
SN - 0022-3956
VL - 181
SP - 560
EP - 569
JO - Journal of Psychiatric Research
JF - Journal of Psychiatric Research
ER -